TERESA PAYNE: Open Payments
NPI 1295106037 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,429 in 182 payments from 17 companies in 2025. Trend: 2023 $2,536 · 2024 $3,746 · 2025 $3,429
Food & beverage: $3,330Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 37 | $596 |
| Janssen Biotech, Inc. | 15 | $401 |
| UCB, Inc. | 27 | $382 |
| ABBVIE INC. | 20 | $321 |
| AstraZeneca Pharmaceuticals LP | 11 | $310 |
| GlaxoSmithKline, LLC. | 11 | $254 |
| Novartis Pharmaceuticals Corporation | 13 | $241 |
| PFIZER INC. | 9 | $184 |
| Radius Health, Inc. | 8 | $160 |
| Aurinia Pharma U.S., Inc. | 11 | $149 |
Products named: Bimzelx, TREMFYA, SAPHNELO, BENLYSTA, COSENTYX, RINVOQ, KRYSTEXXA, XELJANZ.
Industry payments across FL — which companies pay providers there.
